Found 16 matching trials
A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK) PHASE3 The purpose of this study is to evaluate the efficacy of ustekinumab compar...
Show More Location
Tokyo Medical and Dental University Hospital
Learn More & Join Trial
Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab PHASE3 The purpose of this study is to evaluate the efficacy of a treat to target ...
Show More Learn More & Join Trial
Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy PHASE4 With this prospective, randomized, multicentre, parallel group pragmatic no...
Show More Learn More & Join Trial
A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease PHASE3 The primary purpose of this study is to evaluate the efficacy and safety of...
Show More Location
University of California, San Diego
Learn More & Join Trial
A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease PHASE2 The purpose of this study is to examine the safety and efficacy of CNTO 127...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis PHASE3 The purpose of this study is to assess the efficacy of ustekinumab, in adul...
Show More Location
Multiple Locations
Learn More & Join Trial
An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis PHASE3 The purpose of this study is to evaluate the safety and efficacy of ustekin...
Show More Location
Multiple Locations
Learn More & Join Trial
An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis PHASE3 The purpose of this study is to assess the efficacy and safety of ustekinum...
Show More Location
Multiple Locations
Learn More & Join Trial
PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease PHASE4 There are currently three classes of biologic treatments approved in Canada...
Show More Location
University of Calgary
Learn More & Join Trial
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease PHASE2 The purpose of the study is to assess the safety and efficacy of JNJ-643045...
Show More Location
Multiple Locations
Learn More & Join Trial